Responses
Letter
Anti-tumour necrosis factor agents and lipid profile: a class effect?
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 4 December 2008
- Published on: 4 December 2008The lipids after one year therapy with infliximab and etanercept in woman with rheumatoid arthritisShow More
Dear Editor,
We read with the great interest the paper by Garces et al. Anti-tumour necrosis factor agents and lipid profile: a class effect? [1] In this study the investigators showed the different effect on lipid profile between infliximab and etanercept in patient with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). We would like to present the similar study in RA patients treate...
Conflict of Interest:
None declared.